Cargando…

A clinical trial comparing parenteral oxytetracyline and enrofloxacin on time to recovery in sheep lame with acute or chronic footrot in Kashmir, India

BACKGROUND: No clinical trials have been conducted in India on the efficacy of parenteral antibacterials to treat footrot in sheep. In addition, there are no studies worldwide on the efficacy of parenteral antibacterials to treat chronic footrot. Sixty two sheep with acute footrot and 30 sheep with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaler, J, Wani, S A, Hussain, I, Beg, S A, Makhdoomi, M, Kabli, Z A, Green, L E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307477/
https://www.ncbi.nlm.nih.gov/pubmed/22293088
http://dx.doi.org/10.1186/1746-6148-8-12
_version_ 1782227331767599104
author Kaler, J
Wani, S A
Hussain, I
Beg, S A
Makhdoomi, M
Kabli, Z A
Green, L E
author_facet Kaler, J
Wani, S A
Hussain, I
Beg, S A
Makhdoomi, M
Kabli, Z A
Green, L E
author_sort Kaler, J
collection PubMed
description BACKGROUND: No clinical trials have been conducted in India on the efficacy of parenteral antibacterials to treat footrot in sheep. In addition, there are no studies worldwide on the efficacy of parenteral antibacterials to treat chronic footrot. Sixty two sheep with acute footrot and 30 sheep with chronic footrot from 7 villages in Kashmir, India were recruited into two separate trials. Sheep with acute footrot were allocated to one of three treatments using stratified random sampling: long acting parenteral oxytetracycline, long acting parenteral enrofloxacin and topical application of potassium permanganate solution (a traditional treatment used by sheep farmers in India). In a quasi pre-post intervention design, sheep with chronic footrot that had not responded to treatment with potassium permanaganate were randomly allocated to treatment with one of the two parenteral antibacterials mentioned above. Sheep with acute footrot were treated on day 0 and those with chronic footrot on days 0, 3, 6 and 9. Sheep were monitored for up to 28 days after treatment. Time to recovery from lameness and initial healing of lesions was assessed using Kaplan-Meier survival curves, nonparametric log-rank and Wilcoxon sign-rank tests. RESULTS: There was significant correlation in recovery from lameness and presence of healing lesions in sheep with acute (r = 0.94) or chronic (r = 0.98) footrot. Sheep with acute footrot which were treated with parenteral antibacterials had a significantly more rapid recovery from lameness and had healing lesions (median = 7 days) compared with those treated with topical potassium permanganate solution (less than 50% recovered in 28 days). The median time to recovery in sheep with chronic footrot treated with either antibacterial was 17 days; this was significantly lower than the median of 75 days lame before treatment with antibacterials. The median time to recovery for both acute and chronic footrot increased as the severity of lesions increased. There was no difference in time to recovery by age, body condition score, duration lame, or presence of pus in the foot within acute and chronically affected sheep. CONCLUSIONS: We conclude that use of parenteral antibacterials to treat sheep lame with either acute or chronic footrot in India is highly effective. This is likely to improve welfare and give economic benefits to the farmers.
format Online
Article
Text
id pubmed-3307477
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33074772012-03-20 A clinical trial comparing parenteral oxytetracyline and enrofloxacin on time to recovery in sheep lame with acute or chronic footrot in Kashmir, India Kaler, J Wani, S A Hussain, I Beg, S A Makhdoomi, M Kabli, Z A Green, L E BMC Vet Res Research Article BACKGROUND: No clinical trials have been conducted in India on the efficacy of parenteral antibacterials to treat footrot in sheep. In addition, there are no studies worldwide on the efficacy of parenteral antibacterials to treat chronic footrot. Sixty two sheep with acute footrot and 30 sheep with chronic footrot from 7 villages in Kashmir, India were recruited into two separate trials. Sheep with acute footrot were allocated to one of three treatments using stratified random sampling: long acting parenteral oxytetracycline, long acting parenteral enrofloxacin and topical application of potassium permanganate solution (a traditional treatment used by sheep farmers in India). In a quasi pre-post intervention design, sheep with chronic footrot that had not responded to treatment with potassium permanaganate were randomly allocated to treatment with one of the two parenteral antibacterials mentioned above. Sheep with acute footrot were treated on day 0 and those with chronic footrot on days 0, 3, 6 and 9. Sheep were monitored for up to 28 days after treatment. Time to recovery from lameness and initial healing of lesions was assessed using Kaplan-Meier survival curves, nonparametric log-rank and Wilcoxon sign-rank tests. RESULTS: There was significant correlation in recovery from lameness and presence of healing lesions in sheep with acute (r = 0.94) or chronic (r = 0.98) footrot. Sheep with acute footrot which were treated with parenteral antibacterials had a significantly more rapid recovery from lameness and had healing lesions (median = 7 days) compared with those treated with topical potassium permanganate solution (less than 50% recovered in 28 days). The median time to recovery in sheep with chronic footrot treated with either antibacterial was 17 days; this was significantly lower than the median of 75 days lame before treatment with antibacterials. The median time to recovery for both acute and chronic footrot increased as the severity of lesions increased. There was no difference in time to recovery by age, body condition score, duration lame, or presence of pus in the foot within acute and chronically affected sheep. CONCLUSIONS: We conclude that use of parenteral antibacterials to treat sheep lame with either acute or chronic footrot in India is highly effective. This is likely to improve welfare and give economic benefits to the farmers. BioMed Central 2012-01-31 /pmc/articles/PMC3307477/ /pubmed/22293088 http://dx.doi.org/10.1186/1746-6148-8-12 Text en Copyright ©2012 Kaler et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Kaler, J
Wani, S A
Hussain, I
Beg, S A
Makhdoomi, M
Kabli, Z A
Green, L E
A clinical trial comparing parenteral oxytetracyline and enrofloxacin on time to recovery in sheep lame with acute or chronic footrot in Kashmir, India
title A clinical trial comparing parenteral oxytetracyline and enrofloxacin on time to recovery in sheep lame with acute or chronic footrot in Kashmir, India
title_full A clinical trial comparing parenteral oxytetracyline and enrofloxacin on time to recovery in sheep lame with acute or chronic footrot in Kashmir, India
title_fullStr A clinical trial comparing parenteral oxytetracyline and enrofloxacin on time to recovery in sheep lame with acute or chronic footrot in Kashmir, India
title_full_unstemmed A clinical trial comparing parenteral oxytetracyline and enrofloxacin on time to recovery in sheep lame with acute or chronic footrot in Kashmir, India
title_short A clinical trial comparing parenteral oxytetracyline and enrofloxacin on time to recovery in sheep lame with acute or chronic footrot in Kashmir, India
title_sort clinical trial comparing parenteral oxytetracyline and enrofloxacin on time to recovery in sheep lame with acute or chronic footrot in kashmir, india
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307477/
https://www.ncbi.nlm.nih.gov/pubmed/22293088
http://dx.doi.org/10.1186/1746-6148-8-12
work_keys_str_mv AT kalerj aclinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT wanisa aclinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT hussaini aclinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT begsa aclinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT makhdoomim aclinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT kabliza aclinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT greenle aclinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT kalerj clinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT wanisa clinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT hussaini clinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT begsa clinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT makhdoomim clinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT kabliza clinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia
AT greenle clinicaltrialcomparingparenteraloxytetracylineandenrofloxacinontimetorecoveryinsheeplamewithacuteorchronicfootrotinkashmirindia